Currently, there are 291.35M common shares owned by the public and among those 277.90M shares have been available to trade.
The company’s stock has a 5-day price change of 14.35% and 25.65% over the past three months. QBTS shares are trading -13.69% year to date (YTD), with the 12-month market performance up to 298.35% higher. It has a 12-month low price of $0.75 and touched a high of $11.95 over the same period. QBTS has an average intraday trading volume of 77.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -10.14%, 5.74%, and 100.09% respectively.
Institutional ownership of D-Wave Quantum Inc (NYSE: QBTS) shares accounts for 19.49% of the company’s 291.35M shares outstanding.
It has a market capitalization of $2.11B and a beta (3y monthly) value of 0.90. The earnings-per-share (ttm) stands at -$0.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.45% over the week and 14.90% over the month.
Analysts forecast that D-Wave Quantum Inc (QBTS) will achieve an EPS of -0.04 for the current quarter, -0.06 for the next quarter and -0.18 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.05 while analysts give the company a high EPS estimate of -0.05. Comparatively, EPS for the current quarter was -0.1 a year ago. Earnings per share for the fiscal year are expected to increase by 47.69%, and 9.80% over the next financial year. EPS should grow at an annualized rate of 37.48% over the next five years, compared to -0.61% over the past 5-year period.
Looking at the support for the QBTS, a number of firms have released research notes about the stock. B. Riley Securities stated their Buy rating for the stock in a research note on July 25, 2024, with the firm’s price target at $3. Needham coverage for the D-Wave Quantum Inc (QBTS) stock in a research note released on April 08, 2024 offered a Buy rating with a price target of $2.50. Piper Sandler was of a view on October 19, 2022 that the stock is Overweight, while ROTH Capital gave the stock Buy rating on August 30, 2022, issuing a price target of $20.
